Success Story

Avisi Technologies Closes $4 Million Seed Round to Further Develop Glaucoma Treatment Device

Penn spinout Avisi Technologies raised $4.06 million in a seed round led by Accanto Partners. Avisi was co-founded in 2017 by Penn students Rui Jing J., the company’s current CEO, and Brandon Kao and Adarsh Battu, who, at the time, were studying business and engineering. The group developed the idea to use nanotechnology to improve how glaucoma is treated, and are former winners of Penn’s Y-Prize and the President’s Innovation Prize based at the Pennovation Center.

Jiang said the investment funds will be used to help carry out the company’s clinical development of their lead product VisiPlate and to support additional research and development activities. Read more here.

Skip to content